Cost-effectiveness of treatments for chronic hepatitis C
- 1 December 1999
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 107 (6) , 74-78
- https://doi.org/10.1016/s0002-9343(99)00388-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort StudyHepatology, 1998
- 10-year follow-up after interferon-α therapy for chronic hepatitis CHepatology, 1998
- Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis CAnnals of Internal Medicine, 1998
- Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristicsHepatology, 1997
- The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysisJournal of Hepatology, 1997
- Virus Elimination and Histologic Improvement in Patients with Chronic Hepatitis C Treated with Interferon AlphaJournal of Clinical Gastroenterology, 1997
- Modeling therapeutic benefit in the midst of uncertaintyDigestive Diseases and Sciences, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisPublished by Elsevier ,1995